2022 Revenues ($USD) : $5,212,000,000
2022 R&D spend : $356,000,000
2022 Number of Employees : 18,369
Fiscal Year End : 12/31/2021
Company CEO : Deepak Nath, CEO

London-based Smith+Nephew specializes in advanced wound management, orthopedics and trauma and sports medicine. While announcing Q2 2022 results, company officials said they have a strategy to grow the company’s orthopedics business. The plan includes initiatives such as driving operational benefits in orthopedics and transforming the business. S+N has also invested in its orthopedics business by building a new $100 million plant in Malaysia.

In other recent news, the British medtech giant announced that it will build a new R&D and manufacturing facility for its Advanced Wound Management franchise that will move the company outside of its historic home of Hull.  –CN